This market insight discusses the rheumatoid arthritis pharmaceutical drugs currently in the global market as well as those in the development stage. It offers a competitive analysis of the drugs and a forecast of their impact on the market. Drugs in the development stage are segmented by clinical trial phase as well as by drug class. The study covers profiles of late-stage investigational products close to being launched, patent expiration timelines, products in clinical development, launched product profiles, and new product launch timelines.
Key Findings
Key Findings (continued)
Companies to Watch
Defining Healthcare Trends in the Future
Executive Summary—CEO’s Perspective
Market Overview—Definitions
Market Overview—Definitions (continued)
Market Overview—Definitions (continued)
Market Overview—Definitions (continued)
Market Overview—Definitions (continued)
Market Overview—Definitions (continued)
Market Overview—Segmentation
Market Overview—Segmentation (continued)
Market Overview—Segmentation (continued)
Rheumatoid Arthritis Global Incidence
Drivers and Restraints
Competitive Factors and Assessment
Competitive Landscape—Count of Marketed and Pipeline Products
Competitive Landscape—Marketed and Pipeline Products
Marketed Product Analysis
Marketed Product Analysis (continued)
Patent Expiration Timeline
Pipeline Analysis—Products in Clinical Development
Pipeline Analysis—Products in Clinical Development (continued)
Pipeline Analysis—Products in Clinical Development (continued)
Product Launch Timeline
Phase 3 Clinical Program—Next Product Launches
Product Dashboard—Eli Lilly’s Baricitinib
Product Dashboard—Sanofi/Regeneron’s SAR153191/REGN88
Product Dashboard—Biocad’s BCD-020
The Last Word—Three Big Predictions
The Last Word—Discussion
Legal Disclaimer
Market Engineering Methodology
Table of Acronyms Used
Table of Acronyms Used (continued)
Table of Acronyms Used (continued)
Drivers Explained
Drivers Explained (continued)
Drivers Explained (continued)
Drivers Explained (continued)
Restraints Explained
Restraints Explained (continued)
Additional Sources of Information on Rheumatoid Arthritis
Additional Sources of Information on Rheumatoid Arthritis (continued)
Learn More—Next Steps
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
This market insight discusses the rheumatoid arthritis pharmaceutical drugs currently in the global market as well as those in the development stage. It offers a competitive analysis of the drugs and a forecast of their impact on the market. Drugs in the development stage are segmented by clinical trial phase as well as by drug class. The study covers profiles of late-stage investigational products close to being launched, patent expiration timelines, products in clinical development, launched product profiles, and new product launch timelines.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Lucila Rocca |
| WIP Number | NED2-01-00-00-00 |
| Is Prebook | No |
Product and Pipeline Analysis of the Global Rheumatoid Arthritis Therapeutics Market
Product and Pipeline Analysis of the Global Rheumatoid Arthritis Therapeutics Market
Launch of Novel Oral Therapies to Result in Major Market Changes
RELEASE DATE
20-Nov-2014
20-Nov-2014
REGION
North America
North America
Deliverable Type
Market Research
Market Research
Research Code: NED2-01-00-00-00
SKU: LS00131-NA-MR_16972
$3,950.00
In stock
SKU
LS00131-NA-MR_16972